Latest Breaking News On - Angela zubel - Page 1 : vimarsana.com

Repare Therapeutics & Debiopharm Announce First Patient Dosed in Phase 1/1b MYTHIC Trial Evaluating the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition

Repare Therapeutics & Debiopharm Announce First Patient Dosed in Phase 1/1b MYTHIC Trial Evaluating the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United kingdomMaria koehlerAngela zubelRepare therapeutics incExchange commissionCompany nasdaqCompany annual report on formRepare therapeuticsExecutive vice presidentChief medical officerChief development officerPrivate securities litigation reform actAnnual reportDes march

Repare Therapeutics Inc : Repare Therapeutics & Debiopharm Announce First Patient Dosed in Phase 1/1b MYTHIC Trial Evaluating the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition

Repare Therapeutics Inc : Repare Therapeutics & Debiopharm Announce First Patient Dosed in Phase 1/1b MYTHIC Trial Evaluating the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic Lethal Combination of WEE1 AND PKMYT1 Inhibition

Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic Lethal Combination of WEE1 AND PKMYT1 Inhibition
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomAngela zubelMaria koehlerHead of communicationsRepare therapeutics incRepare therapeuticsChief development officerExecutive vice presidentChief medical officer

Debiopharm to Showcase Research Results of Their DDR Inhibitors at the 2024 AACR Conference in San Diego

Debiopharm to Showcase Research Results of Their DDR Inhibitors at the 2024 AACR Conference in San Diego
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan diegoAngela zubelNoemie luongLuke piggottAnne bellonDennis riedlHead of communicationsAmerican association for cancer researchAmerican associationCancer researchChief development officerClinical pharmacology leadPrincipal scientistAssociate principal scientistDamage repair

Debiopharm International SA: DEBIOPHARM SHARES ONCOLOGY PROGRAM UPDATES AT ASCO 2023 FOR NOVEL WEE1 INHIBITOR, AND FIRST-IN-CLASS CA IX THERANOSTIC APPROACH

Debiopharm will highlight diversified approaches and commitment to improving outcomes for patients with cancer at the 2023 American Society of Clinical Oncology Conference A poster presentation

United statesPrnewswire debiopharmHans gelderblomDarrenr feldmanStephanie lheureuxAngela zubelAmerican society of clinical oncology conferenceMd department of medicineHead of communicationsWeill cornell medical collegeMemorial sloan kettering cancer centerMd leiden university medical centerDepartment of medicineAmerican society of clinical oncologyUniversity health networkClinical oncology conference